Shareholding disclosure

Dr. David E. Shaw

Declared position

3%

Threshold

Fell below threshold

Timeline

Published

30.07.2025

Transaction

22.07.2025

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

ZA01-000000000QKD1

Beneficial owner

Dr. David E. Shaw

Declared address

Dr. David E. Shaw, New York, US

D. E. Shaw Valence International, Inc. has entered into a lock-up agreement with Idorsia Ltd ("Idorsia"), Idorsia Pharmaceuticals Ltd and certain holders of Idorsia convertible bonds 2025 (ISIN CH0426820350) (the "CB2025") and/or Idorsia convertible bonds 2028 (ISIN CH1128004079) (the "CB2028") dated 25 February 2025 (the "Lock-Up Agreement") and is thus a member of the lock-up group initially disclosed on 3 March 2025. This disclosure notification only concerns positions held by D. E. Shaw Valence International, Inc. (alongside other purchase positions held by D. E. Shaw Valence International, Inc., D. E. Shaw Valence Investments (Cayman) Limited, and D. E. Shaw Oculus International, Inc.) that are not locked under the Lock-Up Agreement and, hence, are not covered by the lock-up group disclosure.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open